Israelis with real estate investments in Florida are now beginning to assess the damage caused to their properties by Hurricane Irma. Lawrence Sternthal, International Real Estate Shareholder in Greenberg Traurig’s Tel Aviv office, shared with TheMarker Magazine what Israeli investors should consider when examining their home insurance coverage and the challenges foreign investors
Greenberg Traurig
GT Attorneys in Tel Aviv and Other GT Offices Represent Medical Tech Company in $280M Deal
A Greenberg Traurig team of attorneys in Tel Aviv, Fort Lauderdale, Miami, Boston, and New York recently represented BioTelemetry Inc., a publicly traded company based in Pennsylvania, in its $280 million purchase of Switzerland’s LifeWatch AG, a health care technology company.
LifeWatch AG began its way as an Israeli entity in the 1990s and became…
Greenberg Traurig’s Hilarie Bass Takes Over as President of the American Bar Association
The end of August was a special time for Greenberg Traurig, as we celebrated Hilarie Bass taking over as the President of the American Bar Association. Hilarie is a shareholder in our Miami office and is the Co-President of the firm. Hilarie has visited our Tel Aviv office a numbers of times since its opening…
Gary Epstein Named “Lawyer of the Year” by Best Lawyers in America
For the 11th consecutive year, global law firm Greenberg Traurig, LLP has more attorneys listed in Best Lawyers in America than any other law firm in the guide. The 2018 edition of Best Lawyers in America lists 366 Greenberg Traurig attorneys nationwide. (See full list here.) The guide also lists 26 of the…
Greenberg Traurig Number One in Number of Litigation Cases Handled in Past Years
According to a recent study conducted by Lex Machina, a leading US based legal analytics company, over the last eight and a half years Greenberg Traurig attorneys in the US have defended more commercial litigation cases than any other firm, and also filed more commercial disputes on behalf of plaintiffs. This achievement is enhanced by…
Bet-the-Synagogue Case: GT Secures Reversal for Pro Bono Client Congregation Shearith Israel in Hotly Contested Suit
Congregation Shearith Israel, represented pro bono by lead counsel Louis M. Solomon of Greenberg Traurig, LLP, won a complete reversal in the First Circuit Court of Appeals of a lower court decision that had erroneously turned Touro Synagogue over to its tenants.
Congregation Shearith Israel, the country’s oldest Jewish congregation (dating from 1654), has…
GT Tel Aviv Hosts Shurat HaDin Summer 2017 Interns
In late July, the GT Tel Aviv office hosted Shurat HaDin’s 2017 Summer Interns, for a get-together and in-depth presentation on practicing foreign law in Israel as a North American educated attorney.
The head of GT Tel Aviv’s Real Estate practice, Lawrence Sternthal, delivered a presentation of GT Tel Aviv’s international practice to the…
GT’s Rudolph Giuliani and Gary Epstein Opened Trade on TASE for the First Time
Tel Aviv Operating Shareholder Gary Epstein and Former Mayor of New York and Chair of Greenberg Traurig’s Cybersecurity, Privacy and Crisis Management Practice Rudolph Giuliani opened trade on Tel Aviv Stock Exchange (TASE) for the first time in late June.
The event, led by Ittai Ben Zeev, TASE CEO, attracted over 200 young entrepreneurs and…
Greenberg Traurig Client Mitoconix Bio to Take Aim at Huntington’s Disease
Mitoconix Bio, an innovative Israeli startup bred by Israel’s only life science incubator, FutuRx, has recently raised $20 million to develop a promising drug for the treatment of Huntington’s disease and other neurodegenerative disorders, as reported by the Times of Israel.
Both Mitoconix Bio and FutuRx are clients of GT’s Barry Schindler, co-chair…
Health Care & FDA Practice Bulletin No. 5
Welcome to Greenberg Traurig’s Health Care & FDA Practice Bulletin, a collection of timely articles written by our attorneys that are focused on significant developments in health and FDA law. The topics in this issue include the Affordable Care Act, health care fraud and abuse, regulatory updates, FDA news, other health care topics, and upcoming…